Skip to main content

Table 8 Change from Baseline in Weight (kg) and Odds Ratios of ≥7% Weight Gain

From: Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

PLO

0.20 [−0.59, 1.00]

0.65 [0.34, 0.96]

2.88 [2.40, 3.36]

1.17 [0.84, 1.49]

0.34 [− 0.22, 0.89]

1.67 [0.56, 3.92]

ARI

0.44 [− 0.42, 1.30]

2.68 [1.76, 3.61]

0.96 [0.10, 1.83]

0.14 [−0.85, 1.11]

3.50 [1.26, 8.65]

2.67 [0.56, 8.41]

CAR

2.24 [1.66, 2.80]

0.52 [0.07, 0.96]

−0.31 [− 0.95, 0.33]

68.46 [15.56, 231.00]

52.56 [7.42, 205.90]

24.93 [3.35, 95.57]

OLA

−1.71 [−2.29, −1.13]

−2.54 [−3.28, − 1.81]

3.46 [1.91, 5.92]

2.64 [0.74, 6.90]

1.26 [0.34, 3.13]

0.08 [0.01, 0.25]

QUE

−0.83 [− 1.48, − 0.18]

19.08 [0.66, 108.10]

14.68 [0.35, 83.24]

6.85 [0.16, 39.89]

0.43 [0.01, 2.56]

5.98 [0.18, 33.08]

LUR

  1. Note: Weight Change results are on the top-right and numbers represent the mean change [95% credible interval]. ≥7% Weight Gain results are on the bottom-left and results give the odds ratio [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category
  2. Abbreviations: PLO Placebo, ARI Aripiprazole, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine